-
-
-
-
-
-
-
SciSparc Ltd. Announces Additional Positive Results for the Cocaine Addiction Treatment of its Psychedelic-based Pharma Collaboration with Clearmind Medicine Inc.
-
-
-
-
-
-
-
Clearmind Announces Successful Pre-IND Meeting with U.S. FDA for CMND-100 for Alcohol Use Disorder
-
-
-
-
-
-
-
Clearmind Medicine to Partner with Microdose for Psychedelic Capital: Mar 2022 Today, Thursday, March 24th
-
-
-
-
-
-
-
Clearmind Medicine Now Fully Eligible for Settlement through the Depository Trust Company (“DTC”)
-
-
-
-
-
-
-
Clearmind Medicine Launches Study for Binge Eating with The Hebrew University Using its Proprietary MEAI Compound
-
1,174,454 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

